Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

839
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
839
Stress Prevention and Stress Management Techniques VI01:30

Stress Prevention and Stress Management Techniques VI

315
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
315
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-timepoint framework for sensitive and specific single-cell activity screening.

Neuron·2026
Same author

A consensus guide to preclinical indirect calorimetry experiments.

Nature metabolism·2025
Same author

Bone marrow neutrophil density regulates myelopoiesis during obesity and weight loss.

The Journal of experimental medicine·2025
Same author

Overfeeding induces adipose tissue release of distinct mitochondria.

Cell reports·2025
Same author

Author Correction: Macrophage function in adipose tissue homeostasis and metabolic inflammation.

Nature immunology·2023
Same author

Macrophage function in adipose tissue homeostasis and metabolic inflammation.

Nature immunology·2023
Same journal

Targeting cholesterol esterification sensitizes liver cancer to CD8<sup>+</sup> T cell attack by impairing metabolic and redox resilience.

Immunity·2026
Same journal

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same journal

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors.

Immunity·2026
Same journal

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Keeping Off the Weight with DCs.

Ethan A Edwin1, Anthony W Ferrante1

  • 1Department of Medicine, Naomi Berrie Diabetes Center, Columbia University, 1150 St Nicholas Ave, New York, NY 10032, USA.

Immunity
|October 22, 2015
PubMed
Summary
This summary is machine-generated.

Immune cells in fat tissue regulate weight. Ablating dendritic cells worsened autoimmunity and increased fat mass, revealing a novel link between immune cells, autoimmunity, and obesity.

More Related Videos

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.8K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.8K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.5K

Area of Science:

  • Immunology
  • Metabolic disease research
  • Adipose tissue biology

Background:

  • Adipose tissue immune cells modulate insulin sensitivity.
  • Recent research links these cells to fat mass and weight regulation.
  • Dendritic cells play a role in immune responses and metabolic homeostasis.

Purpose of the Study:

  • To investigate the role of perforin-expressing dendritic cells in adipose tissue.
  • To determine the impact of ablating these cells on T cell populations and autoimmunity.
  • To explore the consequences of dendritic cell ablation on adiposity and weight gain.

Main Methods:

  • Utilized genetic ablation techniques to remove perforin-expressing dendritic cells in a mouse model.
  • Analyzed T cell populations and immune cell infiltration in adipose tissue.
  • Assessed changes in fat mass, body weight, and metabolic parameters.

Main Results:

  • Ablation of perforin-expressing dendritic cells led to significant T cell expansion.
  • This expansion was associated with a worsening of autoimmune symptoms.
  • Surprisingly, the ablation resulted in a notable increase in adiposity.

Conclusions:

  • Perforin-expressing dendritic cells are critical regulators of immune homeostasis within adipose tissue.
  • Their absence can exacerbate autoimmunity and promote increased fat accumulation.
  • These findings highlight a complex interplay between immune cells, autoimmunity, and metabolic regulation, offering new therapeutic targets for obesity and autoimmune diseases.